Table 4.
Enterococcus spp. isolates from bloodstream infections’ resistance profiles.
| Agent | MIC50 | MIC90 | Range | Count | CLSI a | EUCAST a | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| %S | %I | %R | Count | %S | %I | %R | Count | |||||
| Amoxicillin-clavulanic acid | ≤1 | >8 | ≤1 to >8 | 1451 | ||||||||
| Piperacillin-tazobactam | 8 | >16 | ≤2 to >16 | 3042 | 64.9 | 0.3 | 34.8 | 3040 | ||||
| Imipenem | 1 | >8 | ≤0.12 to >8 | 1458 | ||||||||
| Meropenem | 8 | >8 | 0.25 to >8 | 1458 | ||||||||
| Cefepime | >16 | >16 | ≤0.5 to >16 | 1458 | ||||||||
| Ceftaroline | 4 | >8 | ≤0.25 to >8 | 5045 | ||||||||
| Ceftriaxone | >8 | >8 | ≤0.06 to >8 | 1458 | ||||||||
| Trimethoprim-sulfamethoxazole | ≤0.5 | >4 | ≤0.5 to >4 | 1458 | ||||||||
| Teicoplanin | ≤2 | >16 | ≤2 to >16 | 5145 | 85.3 | 2.1 | 12.7 | 5145 | 84.7 | 15.3 | 5145 | |
| Vancomycin | 1 | >16 | ≤0.5 to >16 | 5145 | 83.1 | 0.6 | 16.3 | 5145 | 83.1 | 16.9 | 5145 | |
| Tigecycline | ≤0.06 | 0.12 | ≤0.06 to >0.5 | 5142 | 99.6 | 0.4 | 4971 | |||||
| Clindamycin | >2 | >2 | ≤0.25 to >2 | 2246 | ||||||||
| Daptomycin | 1 | 2 | ≤0.25 to >8 | 5144 | ||||||||
| Erythromycin | >16 | >16 | ≤0.12 to >16 | 2245 | 8.2 | 27.5 | 64.2 | 2245 | ||||
| Linezolid | 1 | 2 | ≤0.25 to >8 | 5145 | 99.6 | 0.2 | 0.2 | 5145 | 99.8 | 0.2 | 5145 | |
| Ampicillin | 1 | >8 | ≤0.5 to >8 | 5150 | 66.0 | 34.0 | 5150 | 65.7 | 0.4 | 34.0 | 5150 | |
| Penicillin | 4 | >8 | ≤0.06 to >8 | 1448 | 61.8 | 38.2 | 1448 | |||||
| Ciprofloxacin | >4 | >4 | ≤0.03 to >4 | 1457 | 36.8 | 8.6 | 54.6 | 1457 | 47.4 | 52.6 b | 1457 | |
| Levofloxacin | 4 | >4 | ≤0.5 to >4 | 5151 | 48.4 | 2.0 | 49.6 | 5151 | 50.4 | 49.6 b | 5151 | |
| Moxifloxacin | 2 | >4 | ≤0.25 to >4 | 4262 | ||||||||
| Doxycycline | 8 | >8 | ≤0.06 to >8 | 1353 | 46.0 | 34.5 | 19.5 | 1353 | ||||
| Minocycline | 8 | >8 | ≤1 to >8 | 3691 | 48.1 | 19.9 | 32.1 | 3691 | ||||
| Tetracycline | >8 | >8 | ≤1 to >8 | 5141 | 32.9 | 1.0 | 66.1 | 5141 | ||||
a Criteria as published by CLSI (2021) and EUCAST (2021), b Uncomplicated UTI only. Organisms included: Enterococcus avium (20), E. casseliflavus (44), E. cecorum (1), E. durans (11), E. faecalis (3002), E. faecium (1980), E. gallinarum (68), E. hirae (13), E. mundtii (2), and E. raffinosus (13). Report generated from MVP (https://sentry-mvp.jmilabs.com, assessed on 4 June 2021), a product of JMI Laboratories, on 5 June 2021 11:06:30 GMT/UTC. The data and information are available in the SENTRY Antimicrobial Surveillance Program dataset.